Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

J.J. Castillo, T. Guerrero-Garcia, F. Baldini, E. Tchernonog, G. Cartron, S. Ninkovic, K. Cwynarski, D. Dierickx, T. Tousseyn, F. Lansigan, Y. Linnik, R. Mogollon, J.-T. Navarro, A.J. Olszewski, J.L. Reagan, P. Fedele, M. Gilbertson, G. Grigoriadis, M. Bibas

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusPublished - 2018

Cite this

Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. / Castillo, J.J.; Guerrero-Garcia, T.; Baldini, F.; Tchernonog, E.; Cartron, G.; Ninkovic, S.; Cwynarski, K.; Dierickx, D.; Tousseyn, T.; Lansigan, F.; Linnik, Y.; Mogollon, R.; Navarro, J.-T.; Olszewski, A.J.; Reagan, J.L.; Fedele, P.; Gilbertson, M.; Grigoriadis, G.; Bibas, M.

In: British Journal of Haematology, 2018.

Research output: Contribution to journalArticle

Castillo, JJ, Guerrero-Garcia, T, Baldini, F, Tchernonog, E, Cartron, G, Ninkovic, S, Cwynarski, K, Dierickx, D, Tousseyn, T, Lansigan, F, Linnik, Y, Mogollon, R, Navarro, J-T, Olszewski, AJ, Reagan, JL, Fedele, P, Gilbertson, M, Grigoriadis, G & Bibas, M 2018, 'Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma', British Journal of Haematology. https://doi.org/10.1111/bjh.15156
Castillo, J.J. ; Guerrero-Garcia, T. ; Baldini, F. ; Tchernonog, E. ; Cartron, G. ; Ninkovic, S. ; Cwynarski, K. ; Dierickx, D. ; Tousseyn, T. ; Lansigan, F. ; Linnik, Y. ; Mogollon, R. ; Navarro, J.-T. ; Olszewski, A.J. ; Reagan, J.L. ; Fedele, P. ; Gilbertson, M. ; Grigoriadis, G. ; Bibas, M. / Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. In: British Journal of Haematology. 2018.
@article{31b5250b013340cabb437a3bdbc2051a,
title = "Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma",
author = "J.J. Castillo and T. Guerrero-Garcia and F. Baldini and E. Tchernonog and G. Cartron and S. Ninkovic and K. Cwynarski and D. Dierickx and T. Tousseyn and F. Lansigan and Y. Linnik and R. Mogollon and J.-T. Navarro and A.J. Olszewski and J.L. Reagan and P. Fedele and M. Gilbertson and G. Grigoriadis and M. Bibas",
note = "Export Date: 13 April 2018 Article in Press",
year = "2018",
doi = "10.1111/bjh.15156",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma

AU - Castillo, J.J.

AU - Guerrero-Garcia, T.

AU - Baldini, F.

AU - Tchernonog, E.

AU - Cartron, G.

AU - Ninkovic, S.

AU - Cwynarski, K.

AU - Dierickx, D.

AU - Tousseyn, T.

AU - Lansigan, F.

AU - Linnik, Y.

AU - Mogollon, R.

AU - Navarro, J.-T.

AU - Olszewski, A.J.

AU - Reagan, J.L.

AU - Fedele, P.

AU - Gilbertson, M.

AU - Grigoriadis, G.

AU - Bibas, M.

N1 - Export Date: 13 April 2018 Article in Press

PY - 2018

Y1 - 2018

U2 - 10.1111/bjh.15156

DO - 10.1111/bjh.15156

M3 - Article

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -